Clinical Trial Update: Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical evaluation of nelarabine in Japanese patients with acute lymphoblastic leukemia and lymphoblastic lymphoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic | Phase 1 | Status: COMPLETED